STOCK TITAN

Flotek (FTK) proposes sale of 87,187 shares worth $1.10M

Form 144 filed for Flotek Industries (FTK) reports a proposed sale of 87,187 common shares with an aggregate market value of $1,101,171.81 to be executed on the NYSE on 08/14/2025 through APEX CLEARING.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Form 144 filed for Flotek Industries (FTK) reports a proposed sale of 87,187 common shares with an aggregate market value of $1,101,171.81 to be executed on the NYSE on 08/14/2025 through APEX CLEARING.

The filing shows the shares were acquired by stock option exercises: 24,306 shares on 04/19/2021 and 62,881 shares on 12/05/2023. No securities were reported sold by the person in the past three months. The form includes the filer’s representation that they do not possess undisclosed material adverse information about the issuer. The filing does not disclose the name of the person for whose account the securities will be sold or the filer’s stated relationship to the issuer.

Insights

TL;DR Proposed sale is small relative to outstanding shares and is likely immaterial to company valuation.

The notice covers 87,187 shares with an aggregate market value of $1,101,171.81 against 29,860,000 shares outstanding. That quantity represents about 0.29% of outstanding common shares, indicating the transaction is modest in scale. The shares were obtained via stock option exercises in 2021 and 2023, and there are no reported sales in the prior three months. From a financial-impact perspective, the data in this form alone does not signal material dilution or a change in capital structure.

TL;DR Disclosure is procedurally complete but provides limited context on the seller’s identity or relationship to the issuer.

The filing specifies broker details (APEX CLEARING) and acquisition origins (stock option exercises) and includes the standard representation about absent undisclosed material adverse information. However, the form as provided does not supply the name of the person on whose account the sale is to be made or the filer’s relationship to the issuer, limiting governance transparency. Based solely on the form content, the filing appears routine rather than a governance red flag.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What quantity and value of Flotek (FTK) shares does the Form 144 report?

The form reports a proposed sale of 87,187 shares with an aggregate market value of $1,101,171.81.

When is the proposed sale of FTK shares scheduled and on which exchange?

The approximate date of sale is 08/14/2025 and the sale is to occur on the NYSE.

How were the shares being sold acquired according to the filing?

The shares were acquired by stock option exercises: 24,306 shares on 04/19/2021 and 62,881 shares on 12/05/2023.

Who is the broker handling the proposed FTK sale?

The broker listed is APEX CLEARING with address 350 N St. Paul St Suite 300, Dallas, TX 75201.

Does the filing disclose prior sales by the person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Does the Form 144 identify the person for whose account the securities will be sold or their relationship to Flotek?

The content provided does not include the name of the person for whose account the securities are to be sold nor a stated relationship to the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading